PND9 Exploring Serious Adverse Events Associated With Hospitalizations in a Long-term, Phase 3, Open-Label, Repeat-Dose, Safety Study of Diazepam Nasal Spray for Patients With Epilepsy

Abstract

Authors

J. Wheless M. Sperling R.E. Hogan D. Tarquinio D. Dlugos N. Fountain E. Carrazana A.L. Rabinowicz